Sell Your Pharma Manufacturing Facility and Lease it BackContact Us >


Browse our available pharmaceutical and biotech manufacturing facilities
to find the perfect fit for your unique needs.

Featured Facility

Midwest U.S.

U.S. Small Molecule API Pilot and Commercial Scale Manufacturing Facility

60,000 SF

60,000 SF small molecule API facility with pilot scale and commercial scale capabilities for sale in the Midwest U.S.  Contact Sean McKee at for more information.  UNDER CONTRACT

Marketing Flyer

Available Facilities

Please find below a sampling of Biotechnology, Life Sciences, and Pharmaceutical Facilities we either represent or have knowledge of. If any particular facility is of interest to you or maybe you have more specific needs, please don’t hesitate to contact us at or phone us at 610.293.0900.

Charleston, SC

Medical Device Manufacturing Facility

270,000 SF

PharmaBioSource Realty represented SHL Medical ( on the lease of its new U.S. medical device injection molding manufacturing facility in Charleston, SC.  The facility totals 270,000 SF of space and SHL is planning a $90M investment.  Once operational in 2024, SHL will employ 165 staff to support its growing autoinjector device manufacturing demands. LEASED  

Read Press Release

Buena, NJ

Topicals, Creams and Injectable Fill / Finish Manufacturing Facility

110,000 SF

PharmaBioSource Realty is exclusively marketing an operating topical liquids and creams, and injectable fill / finish manufacturing facility located in the U.S.  The facility houses 4 compounding suites, a dedicated XP-rated solvent suite and 3 packaging lines for topical liquids, creams, ointments, gels and suspensions.  The facility also houses a brand-new injectable fill / finish area with a Bausch VarioSys vial / ampoule filling line.  Interested parties should contact Sean McKee at for a confidential discussion. SOLD

Marketing Flyer

Deals We've Closed

Sellersville, PA

Oral Solids, Liquids, Creams and Ointments Manufacturing and Packaging

221,239 SF

PharmaBioSource Realty exclusively represented G&W Laboratories to divest its oral solids, liquids, creams and ointments manufacturing and packaging operation.  Piramal Pharma Solutions acquired the fully staffed site which also included a supply agreement.

Press Release

Riviera Beach, Florida

Soft Gel Development & Manufacturing Facility

73,550 SF

PharmaBioSource Realty exclusively represented the sale of Micelle BioPharma’s soft gel development, manufacturing and laboratory assets and the lease of its 73,550 SF facility.

Read Press Release

Milford, MA

Biologics API Manufacturing

93,000 SF

PharmaBioSource Realty exclusively represented Shire to sell its Milford, MA roller bottle manufacturing facility to Rentschler Biopharma.

Press Release

Krems, Austria

Biologics / Vaccines Manufacturing

340,000 SF

Shire’s utility-ready biologics / vaccines manufacturing site acquired by Merck Animal Health.

Press Release

Hayward, CA

Biologics API Manufacturing

Shire’s mammalian cell culture manufacturing facility with 3 x 2,000L single-use bioreactors acquired by Lonza Biologics.

Malvern, PA

Small Molecule API R&D Kilo Lab and Pilot Plant

Teva’s 40,000 SF small molecule API research and development facility with kilo labs and pilot plant leased to Flamma.

Brooklyn Park, MN

Biologics API Manufacturing

Baxalta’s mammalian cell culture biologics API manufacturing facility with 2 X 10,000L bioreactors sold to Takeda.

Commack, NY

Solid Dosage Development & Manufacturing

Actavis (former Forest Labs) 103,530 SF solid dosage development and manufacturing facility located on Long Island, NY sold to Ropack Pharma Solutions.

Hauppage, NY

Clinical Packaging

Actavis (former Forest Labs) 110,186 SF clinical packaging and warehouse facility located on Long Island, NY sold to Ropack Pharma Solutions.

Andover, MA

API Development & Manufacturing

Eisai’s 60,000 SF high potency small molecule API development and manufacturing facility sold to Sarepta Therapeutics.

Corona, CA

Solid Dosage Packaging

Actavis (former Watson Pharmaceuticals) 285,433 SF solid dosage packaging facility acquired by Bristol Youcare.

Corona, CA

Solid Dosage Manufacturing

Actavis (former Watson Pharmaceuticals) 196,613 SF solid dosage manufacturing facility acquired by Bristol Youcare.

Pearl River, NY

Vaccine Manufacturing

Leased 78,000 SF of Pfizer’s biologics manufacturing facility to Protein Sciences.

West Lebanon, NH

Biologics API Manufacturing

Olympus Biotech’s 180,000 SF mammaliam cell culture manufacturing facility sold to Novo Nordisk.

Bristol, TN

Solids and Semi-Solids Manufacturing

Sold Pfizer’s 400,000 SF oral and semi-solid dosage form manufacturing facility for tablets, capsules and creams / ointments with controlled substances capabilities to UPM Pharmaceuticals.

Caguas, Puerto Rico

Oral Dosage Manufacturing

475,000 SF Pfizer oral dosage manufacturing operation with high containment and controlled substances capabilities, contracts and staff sold to Neolpharma.

Brooklyn Park, MN

Biologics Manufacturing

Genmab’s 215,000 SF facility with 22,000L of mammalian cell culture capacity sold to Baxter Biosciences.

Rochester, MI

Parenteral Manufacturing

King Pharmaceuticals parenteral manufacturing business with 12 branded generic hospital products sold to JHP Pharmaceuticals.

Horsham, PA

Biologics Pilot Plant

Sold the Neose 50,000 SF GMP pilot plant with preclinical, Phase I and Phase II capability to 2,000L.

Morpeth, UK

API Manufacturing & Dosage Form

Pfizer’s 500,000 SF multi-product, multi-use development and manufacturing campus with staff and contracts sold to Nicholas Piramal.

Dorado, Puerto Rico

Solid Dosage Manufacturing

Sold Biovail’s 175,000 SF solid dosage manufacturing operation to Blu Pharmaceuticals.

Lakewood, NJ

Liquids & Creams Manufacturing

Subleased 221,000 SF of DPT Labs liquids and creams manufacturing facility to Accupac.

Carolina, Puerto Rico

Solid Dosage Manufacturing

Sold AstraZeneca’s 80,000 SF solid dosage manufacturing facility in Carolina, Puerto Rico.

Miami, FL

Sterile Manufacturing

Teva’s 90,000 SF sterile manufacturing facility with associated lab and warehouse acquired by Becton Dickinson.

Piscataway, NJ

Biologics R&D and Pilot Plant

Subleased 30,000 SF of Enzon’s biologics pilot plant and process development laboratories to Axcellerate Pharma.

Cambridge, MA

Biologics Development Labs

Leased 40,000 SF of Draper Labs biotech laboratories to Percivia, a joint venture between DSM and Crucell.

Gaithersburg, MD

Microbial Fermentation and Patch Manufacturing

Leased Intercell’s 54,000 SF microbial fermentation and patch manufacturing facility.

Devon, PA

R&D Laboratories

Nycomed’s 155,200 SF research lab facility with multi-function pilot plant sold to Merck Research Labs.

Success Stories


Representative Clients